|
(b)(6).The device is returning, but has not yet been received by celonova biosciences.A review of the lot history record (lhr) was performed.There were no non-conformances.The lot conforms to its predetermined specifications and requirements, including for stent retention.Stent dislodgement is captured in the risk assessment as a known potential hazard.Investigation is not yet complete.A follow-up report with relevant additional information will be submitted.
|
|
On (b)(6) 2018, during percutaneous coronary intervention (pci) procedure for treatment of an unspecified coronary vessel, a 2.5x18mm, cobra pzf nanocoated coronary stent system was advanced then was withdrawn, undeployed, for an unspecified reason.Prior to attempting re-insertion of the stent system, the physician noted that the stent had dislodged from the stent delivery system, outside of patient anatomy.No adverse patient effects were reported.Additional information was requested.
|